Scarica l'app Stockscreener
1.85
1.09%
0.02
Dopo l'orario di chiusura:
1.85
Precedente Chiudi:
$1.83
Aprire:
$1.85
Volume 24 ore:
2.33M
Relative Volume:
0.38
Capitalizzazione di mercato:
$136.02M
Reddito:
-
Utile/perdita netta:
$-22.83M
Rapporto P/E:
-2.3418
EPS:
-0.79
Flusso di cassa netto:
$-20.87M
1 W Prestazione:
-5.13%
1M Prestazione:
+14.91%
6M Prestazione:
+395.71%
1 anno Prestazione:
+313.13%
Intervallo 1D:
$1.83
$1.9999
Intervallo di 1 settimana:
$1.665
$2.05
Portata 52W:
$0.2223
$3.83
Cognition Therapeutics Inc Stock (CGTX) Company Profile
Nome
Cognition Therapeutics Inc
Settore
Industria
Telefono
412-481-2210
Indirizzo
2403 SIDNEY STREET, PITTSBURGH
Confronta CGTX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CGTX
Cognition Therapeutics Inc
|
1.85 | 153.51M | 0 | -22.83M | -20.87M | -0.79 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.61 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.07 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
569.17 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
837.28 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
318.02 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Cognition Therapeutics Inc Stock (CGTX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-19 | Aggiornamento | B. Riley Securities | Neutral → Buy |
| 2024-07-30 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2021-11-03 | Iniziato | B. Riley Securities | Buy |
| 2021-11-03 | Iniziato | Oppenheimer | Outperform |
Cognition Therapeutics Inc Borsa (CGTX) Ultime notizie
Why Cognition Therapeutics Inc. stock appeals to dividend seekersMarket Growth Summary & Stock Portfolio Risk Management - newser.com
Will Cognition Therapeutics Inc. stock benefit from commodity pricesMarket Activity Report & Consistent Profit Trading Strategies - newser.com
Smart tools for monitoring Cognition Therapeutics Inc.’s price actionMarket Movement Recap & High Accuracy Buy Signal Tips - newser.com
Visual analytics tools that track Cognition Therapeutics Inc. performanceTake Profit & Daily Growth Stock Investment Tips - newser.com
Will Cognition Therapeutics Inc. stock benefit from upcoming earnings reportsJuly 2025 Summary & Risk Controlled Daily Plans - newser.com
Evaluating Cognition Therapeutics Inc. with trendline analysisJuly 2025 PostEarnings & Weekly Breakout Opportunity Watchlist - newser.com
Pattern recognition hints at Cognition Therapeutics Inc. upside2025 Institutional Moves & Weekly Breakout Opportunity Watchlist - newser.com
Can swing trading help recover from Cognition Therapeutics Inc. lossesMarket Activity Summary & Fast Moving Market Watchlists - newser.com
Cognition Therapeutics, Inc.Common Stock (NQ: - FinancialContent
Is it too late to sell Cognition Therapeutics Inc.Quarterly Trade Report & High Win Rate Trade Tips - newser.com
Cognition Therapeutics' (CGTX) "Sell (E+)" Rating Reaffirmed at Weiss Ratings - MarketBeat
Is Cognition Therapeutics Inc. showing signs of accumulationQuarterly Earnings Report & Low Risk High Reward Trade Ideas - newser.com
Cognition Therapeutics (CGTX) Moves to Buy: Rationale Behind the Upgrade - sharewise.com
Cognition Therapeutics (NASDAQ:CGTX) Stock Price Up 13.6%Still a Buy? - MarketBeat
Will Cognition Therapeutics Inc. benefit from macro trendsMarket Performance Recap & Risk Controlled Swing Trade Alerts - newser.com
How hedge fund analytics apply to Cognition Therapeutics Inc. stock2025 AllTime Highs & Verified Momentum Stock Alerts - newser.com
Has Cognition Therapeutics Inc. found a price floor2025 AllTime Highs & Reliable Intraday Trade Alerts - newser.com
Analyzing drawdowns of Cognition Therapeutics Inc. with statistical toolsWeekly Trend Recap & AI Driven Stock Movement Reports - newser.com
Is it time to cut losses on Cognition Therapeutics Inc.2025 Performance Recap & AI Driven Stock Reports - newser.com
Has Cognition Therapeutics Inc. formed a bullish divergenceQuarterly Market Summary & Daily Oversold Stock Bounce Ideas - newser.com
Does Cognition Therapeutics Inc. stock trade at a discount to peersWeekly Investment Recap & Capital Efficient Trading Techniques - newser.com
Is Cognition Therapeutics Inc. stock entering bullish territoryJuly 2025 Outlook & Weekly Top Gainers Alerts - newser.com
Can Cognition Therapeutics Inc. stock hit record highs againEarnings Risk Report & Verified Trade Idea Suggestions - newser.com
Cognition Therapeutics, Inc. (NASDAQ:CGTX) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Chart based analysis of Cognition Therapeutics Inc. trends2025 Big Picture & Short-Term High Return Strategies - newser.com
What drives Cognition Therapeutics Inc stock priceStock Split Announcements & Budget Friendly Trading Ideas - earlytimes.in
Cognition Therapeutics Inc Azioni (CGTX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Cognition Therapeutics Inc Azioni (CGTX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Ricciardi Lisa | CEO & President |
Jan 31 '25 |
Buy |
0.77 |
38,851 |
30,001 |
38,851 |
2.96%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):